The short version of GIP receptor fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
Dual agonism at the GIP and GLP-1 receptors underlies the observed pharmacology. Activation of GLP-1 receptors raises glucose-dependent insulin release, lowers glucagon secretion, slows gastric emptying and reduces appetite. GIP receptor activation contributes additional effects on adipose tissue and on energy balance, and the combined action on appetite appears larger than either pathway alone in animal models. Signalling bias and the relative contribution of each receptor arm to weight-related effects remain areas of active investigation.
Structure-activity work shows that fatty acid length, linker chemistry and the position of acylation all influence albumin affinity and receptor potency. Plasma protein binding exceeds 99 percent, which restricts distribution and slows renal clearance. Degradation proceeds largely through general proteolysis and fatty acid oxidation rather than cytochrome P450 metabolism, so exposure to common oxidative drug interactions is limited. Whether these clearance routes vary meaningfully between individuals is not fully established.
In clinical research, tirzepatide has been studied in randomized controlled trials for glycemic control and body weight reduction. These trials typically measure changes in hemoglobin A1c and body weight over periods of several months. The drug is administered by subcutaneous injection, and its pharmacokinetic profile supports once-weekly dosing. Post-marketing surveillance continues to evaluate long-term outcomes and rare adverse events.
Tirzepatide is a synthetic peptide that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The molecule contains 39 amino acids and features a C20 fatty diacid moiety attached via a linker, which promotes albumin binding and extends its circulating half-life. Its sequence incorporates non-natural amino acids and modifications that reduce susceptibility to degradation by dipeptidyl peptidase-4. This dual receptor activity distinguishes it from selective GLP-1 receptor agonists.
The GIP receptor is expressed in pancreatic islets, adipose tissue, and the central nervous system, while GLP-1 receptors are found in pancreatic islets, the gastrointestinal tract, and the brain. Activation of both receptors can enhance glucose-dependent insulin secretion and reduce glucagon release. The relative contribution of each receptor to the overall pharmacological effect remains an area of ongoing investigation. Preclinical studies suggest that GIP receptor agonism may modulate appetite and energy balance, but the precise mechanisms in humans are not fully established.
| Property | Value | Notes |
|---|---|---|
| Molar mass | approximately 4813 Da | calculated from the 39-residue sequence |
| Appearance | white to off-white powder | typical of lyophilised peptide material |
| Solubility class | freely soluble in water | measured value depends on salt form and pH |
| Plasma protein binding | >99 percent | linked to the fatty diacid side chain |
| Class | dual GIP and GLP-1 receptor agonist | receptor activity varies with the assay used |
Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.
Tirzepatide is a synthetic peptide composed of 39 amino acids. It acts as a dual agonist at two incretin receptors, the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. The molecule was designed by modifying the native sequence of glucose-dependent insulinotropic polypeptide to improve metabolic stability and extend its circulation time. Its structure includes several non-natural amino acid residues and a fatty acid side chain. These features distinguish it from earlier single-receptor incretin analogs studied in the same period.
Pharmacologically, tirzepatide activates two distinct G protein-coupled receptors: the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. Binding at each target triggers cyclic AMP accumulation and downstream signaling in pancreatic beta cells, adipose tissue and the central nervous system. Because the two pathways overlap only partially, the combined effect on insulin secretion, glucagon suppression and appetite signaling differs from that of selective single-receptor compounds. Affinity is not equal across the two targets, and the clinical meaning of that imbalance remains an area of active study.
Clinical research programs have evaluated tirzepatide in adults with type 2 diabetes and in adults with obesity or excess weight. Trials generally reported reductions in glycated hemoglobin and body weight across treatment periods of several months. Since these studies enrolled defined populations under controlled conditions, the findings describe group averages rather than individual outcomes. Open questions include the durability of effects after treatment stops, variation among subgroups, and the long-term consequences of sustained dual receptor stimulation. Published trial summaries should be consulted for exact measurements rather than secondary accounts.
Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its backbone derives from the native glucose-dependent insulinotropic polypeptide sequence, altered at several positions to resist enzymatic cleavage. A fatty diacid group attached through a linker extends plasma residence time by promoting reversible binding to serum albumin. The molecule carries a net negative charge near physiological pH and has a reported molecular weight close to 4813 daltons. These features separate it from shorter incretin analogs and account for its prolonged dosing interval.
=== For the political right === Both liberals and neoconservatives in the United States celebrated the dissolution of the Soviet Union. Ideas such as Francis Fukuyama's end of history and Charles Krauthammer's unipolar moment gained prominence to describe the victory of Western liberal democracy. At the same time, both sides of the political spectrum in the US criticized the George H. W. Bush administration for its comparative cautiousness and political support of Gorbachev over more pro-democracy and nationalist forces in the Soviet Union.
== Health facility workload == The workload of a health facility is often used to indicate its size. Large health facilities are those with a greater patient load. In Australia the workload of a health facility is used to determine the level of government funding provided to that facility. The government measures a facility (or health practice) in terms of its standard whole patient equivalent (SWPE). The SWPE calculation is determined by analysis of the patients that attend that facility. The calculation takes into account the proportion of health services (in dollars) rendered at that facility relative to others that each patient attends. It includes a weighting factor based on each patients' demography to account for the varied levels of services required by patients depending on their gender and age. The premise of weighting is that patients require different levels of health services depending on their age and gender. For example, the average male patient requires fewer consultations than his older and infant counterparts. The table shows the weighting factors used in the standardization of workloads. Table: Age by Sex Weights for SWPE Standardisation
NanoSIMS was used to study and prove for the first time the nitrogen fixing abilities of bacteria and archaea from the deep ocean by supplying 15N nitrogen contain compounds to sediment samples. NanoSIMS can also be used to estimate growth rate of organisms, as the amount of carbon or other substrate accumulated inside the cell allows for estimation of how much biomass is being generated.
Tetra Pak is a Swedish multinational food packaging and processing company headquartered in Switzerland. The company offers packaging, filling machines and processing for dairy, beverages, cheese, ice cream and prepared food, including distribution tools like accumulators, cap applicators, conveyors, crate packers, film wrappers, line controllers and straw applicators. Tetra Pak was founded by Ruben Rausing and built on Erik Wallenberg's innovation, a tetrahedron-shaped plastic-coated paper carton, from which the company name was derived. In the 1960s and 1970s, the development of the Tetra Brik package and the aseptic packaging technology made supply possible without the need for a cold chain, substantially facilitating distribution and storage. From the beginning of the 1950s to the mid-1990s, the company was headed by Rausing's two sons, Hans and Gad, who took the company from a family business with six employees in 1954 to a multinational corporation, operating in more than 160 countries and with over 25,000 employees as of 2021. The company is privately owned by the family of Gad Rausing through the Swiss-based holding company Tetra Laval, which also includes the dairy farming equipment producer DeLaval and the PET bottle manufacturer Sidel.
Viserys inherited the stability and prosperity of Jaehaerys' 55-year rule, with a full treasury and friendly relations between great houses across the realm. House Targaryen experienced the peak of its power during Viserys' rule, as it had the most dragons and family members recorded since the infamous Doom of Valyria. Viserys' accession was honored in a great tourney at Maidenpool in 104 AC, where the knight Ser Criston Cole defeated the fearsome Daemon in rounds of melee and joust. Seeking to maintain the warmth exuded by Jaehaerys, Viserys had the eight-year old Rhaenyra serve as his cupbearer and accompany him at large social gatherings, where she was beloved and nicknamed "The Realm's Delight". Viserys appointed Daemon as the Master of Coin and later Master of Laws in his small council, where Daemon had a bitter rivalry with the Hand of the King Ser Otto Hightower. To diffuse the tension, Viserys appointed Daemon as the Commander of the City Watch. Otto was still fearful of Daemon potentially succeeding Viserys, and attempted to convince Viserys to name Rhaenyra as his heir. Viserys refused his proposal, and asserted that he and Aemma would have a male son for an heir soon enough. In 105 AC, Aemma perished while giving birth to their son Baelon, who passed away a day later. Following the tragedy, Daemon was heard making drunken comments about Baelon being the "heir for a day" on the Street of Silk, which infuriated Viserys.
Sources: en.wikipedia.org
66B Public Health Nurse 66C Psychiatric/Mental Health Nurse 66E Perioperative Nurse 66F Nurse Anesthetist 66G Obstetrics and Gynecology 66H Medical-Surgical Nurse 66N Generalist Nurse 66P Family Nurse Practitioner 66R Psychiatric Nurse Practitioner 66S Critical Care Nurse 66T Emergency Room Nurse 66W Certified Nurse Midwife Skill Identifier
== History == LAAM was approved in 1993 by the U.S. Food and Drug Administration for use in the treatment of opioid dependence. In 2001, LAAM was removed from the European market due to reports of life-threatening ventricular rhythm disorders. In 2003, Roxane Laboratories, Inc. discontinued Orlaam in the US.
== History == MDDMA was first described in the scientific literature by Alexander Shulgin and colleagues by 1980. Subsequently, it was described in greater detail by Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved) in 1991. The drug was described as a possible novel designer drug in 2025. David E. Olson and colleagues characterized (R)-MDDMA as a non-hallucinogenic psychoplastogen with antidepressant-like effects and improved safety relative to MDMA in 2026.
Carbon dioxide occupies a different binding site on the hemoglobin. At tissues, where carbon dioxide concentration is higher, carbon dioxide binds to allosteric site of hemoglobin, facilitating unloading of oxygen from hemoglobin and ultimately its removal from the body after the oxygen has been released to tissues undergoing metabolism. This increased affinity for carbon dioxide by the venous blood is known as the Bohr effect. Through the enzyme carbonic anhydrase, carbon dioxide reacts with water to give carbonic acid, which decomposes into bicarbonate and protons:
Alice in Chains released their debut album, Facelift, in August 1990 through Columbia Records. Inspired by the music of Black Sabbath, Deep Purple, and Motörhead, the album was initially unsuccessful; the band's first live performances were local shows and festivals around Seattle. Their first tour came as a supporting act to Extreme for a month. Extreme themselves had yet to reach fame and were playing their first tour; neither band drew well. Alice in Chains followed with an opening slot on a tour with Iggy Pop in November 1990, but the band was similarly received with indifference. Their fortunes began to turn when the video for their breakout single, "Man in the Box", landed regular rotation on MTV, beating Blue Murder for a slot on the channel's "Buzz Bin". With newfound momentum, the group secured two supporting slots on two high-profile tours: first, they were selected to join thrash metal bands Anthrax, Megadeth, and Slayer, on the Clash of the Titans Tour in mid-1991, having replaced opening act Death Angel after the band was involved in a bus accident that left its drummer Andy Galeon critically injured and unable to perform. They were then appointed to a slot on Van Halen's For Unlawful Carnal Knowledge Tour later that year; Van Halen frontman Sammy Hagar personally selected the band. Sales of Facelift increased drastically, and by September 1991, it had been certified gold by the Recording Industry Association of America (RIAA).
Sources: en.wikipedia.org
== History == Rose Pharma was formerly known as Gastrotech Pharma and founded in 2003. It has a core interest in gastroenterology and was initially established to exploit novel peptide hormones regulating GI and nutritional function. Rose Pharma currently works mainly in the research and development of its main drug, ROSE-010.
An increase in the expression of Group 2 mGluRs, which could arise from a chronic under stimulation of these receptors, has been associated with schizophrenia. An increase in levels of system Xc- has also been found in postmortem schizophrenia patients, indicating that there may have been a decrease in net function of these receptors as well, leading to greater expression. It has been observed that Schizophrenia patients have a decreased level of glutathione in their prefrontal cortex, further supporting the conclusion that system Xc- may not be functioning properly. Clinical trials have shown therapeutic potential for N-acetylcysteine in treating schizophrenia. Again, changes in EAATs due to disruptions in Glutamate homeostasis may also be involved. Recent study showed that mRNA expression levels of both SLC3A2 and SLC7A11 in WBCs of schizophrenia patients are lower than that of healthy individuals. The finding supports the hypo-glutamatergic neurotransmission hypothesis in schizophrenia.
In 1888 Eddy became close to another of her students, Ebenezer Johnson Foster, a homeopath and graduate of the Hahnemann Medical College. He was 41 and she was 67, but apparently in need of affection and loyalty she adopted him legally in November that year, and he changed his name to Ebenezer Johnson Foster Eddy. A year later, in October 1889, Eddy closed the Massachusetts Metaphysical College; according to Bates and Dittemore, the state attorney was investigating colleges that were fraudulently graduating medical students. She also foreclosed the mortgage on the land in Boston the church had purchased, then purchased it herself for $5,000 through a middle man, though it was worth considerably more. She told the church they could have the land for their building on condition they formally dissolve the church; this was apparently intended to quash internal rebellions that had been bothering her. The following year she dissolved the National Christian Science Association. Wilson writes that the dissolutions allowed her to create a central church controlled by a five-person board of directors that answered only to her, which gave the church a stability that helped it survive her death. The cornerstone of The First Church of Christ, Scientist, containing the Bible, Eddy's writings and a list of directors and financial contributors, was laid in May 1894 in the Back Bay area of Boston. Church members raised funds for the construction, and the building was finished in December 1894 at a cost of $250,000.
In Season 9, Roseanne and Jackie win a state lottery in excess of $108 million. At the end of the season, it is revealed that they never won the lottery and most of what previously happened on the show is actually from a fictional book Roseanne wrote. Her account of Dan having an affair was false and he actually suffered a fatal heart attack at the end of Season 8. Roseanne explains that his death was as if he had been unfaithful and left her. However, in Season 10, set twenty years later, the events of Season 9 are ret-conned out of existence. By this time, Roseanne is still married to Dan and is now a grandmother of three and posthumously of four. In 2018, Roseanne Barr was fired from the show after she wrote a racist tweet describing Valerie Jarrett, a black woman and one of President Barack Obama's senior advisers, as the offspring of the "Muslim Brotherhood & Planet of the Apes." In the spin-off The Conners, Roseanne has died of an accidental opioid overdose. The series, which ran for seven seasons, concluded with Dan suing the company which prescribed the opioid pills for Roseanne. In June 2010, Entertainment Weekly named Roseanne one of the 100 Greatest Characters of the Last 20 Years. In 2009, she was listed in the Top 5 Classic TV Moms by Film.com. In May 2012, she was one of the 12 moms chosen by users of iVillage on their list of "Mommy Dearest: The TV Moms You Love". AOL named her the 11th Most Memorable Female TV Character.
Sources: en.wikipedia.org
It is a synthetic peptide of 39 amino acids bearing a lipid side chain. Its size and architecture place it outside the small-molecule class, and laboratories generally handle it with the precautions used for biologic-like molecules.
The fatty diacid side chain promotes strong binding to serum albumin, which slows clearance and yields a half-life of roughly five days. That profile supports once-weekly administration in clinical use.
In vitro assays detect activity at both the GIP and GLP-1 receptors, but the activity ratio depends on the assay system and the signalling pathway measured. The relative contribution of each receptor to clinical effects is still being characterised.
It activates both GIP and GLP-1 receptors. This dual action differentiates it from selective GLP-1 agonists.